Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.36
-0.05 (-0.92%)
Aug 10, 2026, 12:38 PM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $878.2 million as of August 10, 2026. Its market cap has increased by 239.17% in one year.
Market Cap
878.20M
Enterprise Value
678.61M
1-Year Change
239.17%
Ranking
Category
Stock Price
$5.36
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $878.20M, an increase of 37.32%. That is a compound annual growth rate of 5.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 878.20M | 17.37% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Omeros | 958.97M |
| Geron | 950.86M |
| Arbutus Biopharma | 914.60M |
| Aura Biosciences | 881.29M |
| Theravance Biopharma | 877.45M |
| Design Therapeutics | 875.52M |
| Kura Oncology | 849.57M |
| SpyGlass Pharma | 846.57M |